Supernus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
SUPN Supernus Pharmaceuticals Inc
AMWL American Well Corp
DGLD.NV Credit Suisse AG
HMPQ HempAmericana Inc
$SPMCKCP S&P GSCI Coffee Multiple Contract (U
WYNN Wynn Resorts Ltd
BAC Bank of America Corp
KNDI Kandi Technologies Group Inc
$RFTREES Refinitiv Eurozone ESG Select Index
TCEHY Tencent Holdings Ltd
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate), its two treatments for patients with epilepsy. In addition, it is developing multiple product candidates in psychiatry to address unmet medical needs and market opportunities for the treatment of impulsive aggression (IA) and for the treatment of attention deficit hyperactivity disorder (ADHD). It is developing SPN-810 (molindone hydrochloride) to treat IA in patients having ADHD. It is developing SPN-812 (viloxazine hydrochloride) as a candidate to treat patients having ADHD. The Company's neurology portfolio consists of Oxtellar XR and Trokendi XR, which are the first once-daily extended release oxcarbazepine and topiramate products, respectively, indicated for epilepsy in the United States market.

Postmarket

Last Trade
Delayed
$29.20
-0.02 (-0.07%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$29.22
Day's Change
0.43 (1.49%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
29.80
Day's Low
28.49
Volume
(Above Average)
Volume:
690,133

10-day average volume:
582,146
690,133
  • Prev Close
    28.79
  • Today's Open
    28.74
  • Day's Range
    28.49-29.80
  • Avg Vol (10-day)
    582.1K
  • Last (time)
    4:00p ET 01/15/21
  • Last (size)
    40
  • 52-Wk Range
    13.12 - 29.80
    LowHigh
  • (03/18/20 - 01/15/21)
    1.95%
  • 59.1%
  • Market Cap
    1.5B
  • Shares Outstanding
    52.7M
  • 2.41
  • 11.95x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.3
  • 99.37
  • (% of float 12/31/20)
    12.64

Latest News

January 06, 2021
5:29 pm ET
Globe Newswire
December 23, 2020
8:30 am ET
PR Newswire
December 22, 2020
6:53 pm ET
MarketWatch
November 26, 2020
12:30 am ET
Globe Newswire
November 22, 2020
1:37 am ET
Globe Newswire
November 19, 2020
12:30 pm ET
BusinessWire
November 18, 2020
10:00 pm ET
Globe Newswire
4:18 pm ET
BusinessWire
November 16, 2020
11:00 pm ET
Globe Newswire
November 11, 2020
11:13 pm ET
Globe Newswire
9:45 pm ET
PR Newswire
November 09, 2020
11:04 pm ET
Globe Newswire
November 04, 2020
7:17 am ET
Accesswire
October 27, 2020
5:34 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.